Non-small cell lung cancer predictive biomarker testing via immunocytochemistry: Ways of future past?
1Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.
Cancer Cytopathology
|May 4, 2019
Abstract
No abstract available in PubMed .
Keywords:
ALKEGFRNTRKPD-L1ROS1biomarker testingguidelineimmunocytochemistryimmunohistochemistrynon-small cell lung cancerMore Related Videos
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
10.9K
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
16.1K
